Mycoses

Article	Citations
Author Index	205
	160
State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG)	132
Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia	110
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	85
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	54
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	50
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	46
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	45
Physicians' knowledge of invasive fungal disease in China	44
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	40
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	40
Review Article White Piedra: Review of 131 cases	39
Changing demographics and risk factors for cryptococcosis: A 12‐year review at a tertiary care centre	39
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	37
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	37
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	33
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	33
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	31
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	31
Emergence of Candida auris in intensive care units in Algeria	31
Issue Information	30
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	30
Issue Information	29
Issue Information	28

A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	27
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	27
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	27
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	27
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	26
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	25
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	25
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	25
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	24
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	24
Cover Image	24
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	23
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	23
Issue Information	23
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	22
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	22
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	22
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	21
CARD9 mutations in patients with fungal infections: An update from the last 5 years	21
Diagnostic performance of noncultural methods for central nervous system aspergillosis	21
Performance of the RealStar®Pneumocystis jirovecii PCR kit for the diagnosis of Pneumocystis pneumonia	21
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	20
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	20
Tinea pedis in underrepresented groups: All of Us database analysis	20
	20
	19
	19
	19
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	18
	18
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	17
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	17
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	17
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	17
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	17
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	17
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	17
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	17
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	16
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	16
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	16
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries	16
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	16
Issue Information	15
Immune reconstitution inflammatory syndrome in non‐HIV cryptococcal meningitis: Cross‐talk between pathogen and host	15
	15
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	15
	15
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	15
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	14

Morphological and genetic identification of fungal genus/species in formalin‐fixed, paraffin‐embedded specimens obtained from patients with histologically proven fungal infection	14
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	14
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	14
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	14
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	14
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	14
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	13
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	13
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	13
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	13
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	13
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	12
Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients	12
	12
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections	12
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	12
	12
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	12
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	12
Posters	11
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	11
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	11
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	11
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections	11
	11
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	11
Expert recommendations for prevention and management of Candida auris transmission	11
Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis—A Six‐year Retrospective Cohort Study	11
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	11
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	11
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	11
Issue Information	11
Aspergillus nodules: Natural history and the effect of antifungals	11
	11
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	10
Epidemiological analysis of nail aspergillosis and non‐dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France	10
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	10
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	10
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	10
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	10
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	10
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	10
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	10
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	10
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	10
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis	10
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	10
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	10
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	9
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	9
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	9
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	9
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	9
Abstracts	9
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	9
Updated estimation of the burden of fungal disease in Vietnam	9
Coccidioidomycosis in Oklahoma: A retrospective case series	9
Issue Information	9
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	9
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	8
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	8
Time and cost‐efficient identification of Trichophyton indotineae	8
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	8
Issue Information	8
	8
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	8
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	8
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	8
Invasive fungal infections in acute and chronic liver impairment: A systematic review	8
Issue Information	8
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	8
Serious fungal disease incidence and prevalence in Indonesia	8
Paediatric cutaneous mucormycosis: A case report and review of the literature	8
Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador	8
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	8
	8
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	7
Altered skin fungal and bacterial community compositions in tinea capitis	7
A simple high‐volume culture technique—Good substitute for polymerase chain reaction for the detection of Aspergillus species in bronchoalveolar lavage samples	7
Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance	7

Dermatophytes and skin dermatophytoses in Southeast Asia—First epidemiological survey from Cambodia	7
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real‐life settings: A nationwide population‐based cohort study	7
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	7
Molecular genotyping of Candidaalbicans isolated from different sites may trace the etiological infection routes: Observation in China	7
Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China	7
Diagnostic performance of real‐time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis	7
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis	7
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals	7
A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India	7
Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells	7
An open‐label non‐inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma	7
First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment	7
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	7
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital	7